Moderna (MRNA) And Merck (MRK) Melanoma Vaccine Trial Success Sparks Massive Stock Surge And Investor Caution

Moderna’s personalized mRNA cancer vaccine has shown success in a late-stage clinical trial, potentially transforming how doctors treat the deadliest form of skin cancer. The vaccine, developed in combination with Merck’s immunotherapy Keytruda, met its primary goals in the Phase 3 INTerpath-001 study involving more than 1,100 patients with higher-risk or advanced melanoma. Patients enrolled…

Read More

Trump’s 1,000-Launch Space Ambition Opens The Door For SPCX, RKLB, ASTS And LUNR

President Donald Trump has signed a National Security Presidential Memorandum targeting more than 1,000 U.S. launches and reentries annually by 2030. The directive aims to usher in what the administration calls a “Golden Age of Space Transportation,” with sweeping changes to how launches are permitted and managed. The policy calls for faster permitting and environmental…

Read More

IonQ (IONQ) Lands NRO Space Contract, Signaling A Broader Defense And Quantum Strategy

IonQ (IONQ) announced in early August 2026 that its Space Division, formerly known as Capella, secured a contract with the U.S. National Reconnaissance Office. The contract supports the NRO’s Radar Commercial Augmentation program, which supplements government satellite capabilities with commercial radar imagery services. At first glance, the deal appears to be a satellite imaging award…

Read More

RTX (RTX) Lands $22.9 Billion Tomahawk Deal To Boost Precision-Strike Output

Raytheon, a subsidiary of RTX Corporation (RTX), has secured a seven-year, $22.9 billion contract to accelerate Tomahawk cruise missile production for the U.S. Navy and allied forces. The contract was awarded on August 17, 2026, and establishes a long-term framework designed to significantly increase missile output while reinforcing Raytheon’s standing in the precision-strike market. Under…

Read More

Couples In Their 50s With $1.5 Million In Traditional 401(k)s Ask Whether Roth Conversions Make Sense Now

For many Americans approaching retirement, the question of when to begin Roth conversions is among the most consequential financial decisions they will face. A couple in their 50s holding $1.5 million in traditional 401(k) accounts are weighing whether now is the right time to begin converting those funds into a Roth account. The core appeal…

Read More

Bessent’s Treasury Market Interventions Fall Flat As Bond Yields Climb Higher

Treasury Secretary Scott Bessent insists he has a “big toolkit” to address mounting pressures in the U.S. government bond market, but his efforts so far have produced limited results. A two-pronged strategy combining accelerated buybacks with public reassurances has done little to calm investor anxiety or push longer-dated yields durably lower. The Treasury’s Wednesday announcement…

Read More

AST SpaceMobile (ASTS) Faces $15 Million Lawsuit Over Disputed Finder’s Fees

AST SpaceMobile (ASTS) is facing a legal challenge from Delclaux Partners, which has filed a lawsuit seeking more than $15 million in disputed contractual finder’s fees. The lawsuit centers on alleged unpaid compensation that Delclaux Partners claims is linked to financing arrangements it helped source for the satellite company. The case raises significant questions about…

Read More